Content

Grounded in original research, Jinfo Content helps you turn our insight into action on critical information challenges.

Available through a Jinfo Subscription, our reports and recorded webinars bring you practical ideas, case studies, tips and models for change.

Filter the list below:

Article

Chris Porter Product Review of PR Newswire's Agility Platform: Sources, Content and Coverage
27th March 2014

In the second part of his review Chris Porter looks at traditional and social media content coverage in PR Newswire's Agility platform, a workflow tool for PR professionals. Information is also given on PR Newswire’s proprietary media contacts database.

Read

Article

Yulia Aspinall Product Review of PharmaCircle: Value, Development, Help & Pricing
26th March 2014

In the final part of Yulia Aspinall's review of PharmaCircle, we look at the value this online source offers biopharmaceutical companies, and its development plans. Competing products are also mentioned along with our view on the customer service and pricing.

Read

Article

Yulia Aspinall Product Review of PharmaCircle: Technology - Search; Outputs & Alerts; User Interface
25th March 2014

In the third part of our review of PharmaCircle, an online resource for professionals in the biopharmaceutical industry, Yulia Aspinall looks into its unique technology features which allow search and data mining options which facilitate insights not otherwise possible.

Read

Article

Chris Porter Product Review of PR Newswire's Agility Platform: Introduction and Contact Details
25th March 2014

Chris Porter reviews PR Newswire's Agility, an integrated media monitoring and targeting platform for PR and marketing professionals. The first part of the review introduces the company and product.

Read

Article

Tim Buckley Owen Compliance Costs Keep Rising, But So Do the Opportunities
25th March 2014

The cost of regulatory compliance continues to soar, not just because of the volume of regulation but also because of continuing uncertainty on the part of some regulators over what's actually needed. Whether it's Know Your Customer for financial crime and money laundering or Europe's latest thinking on what kind of privacy and data protection regime it requires in a big data era, the opportunities for compliance work just keep on growing.

Read

Article

Yulia Aspinall Product Review of PharmaCircle: Sources, Content and Coverage
24th March 2014

In the second part of our review of PharmaCircle, an online resource for professionals in the biopharmaceutical industry, Yulia Aspinall looks at how it covers information needs at all stages of the drug research, development and marketing process. The "living" database includes international coverage with some documents translated and made searchable.

Read

Article

Penny Crossland Mini Review: Boardroom Insiders
21st March 2014

Penny Crossland's Mini Review of Boardroom Insiders explains how it provides enterprise sales professionals with executive intelligence that enables them to engage with potential customers and sell bigger deals, faster.

Read

Article

Tim Buckley Owen Big Data - Talent Gap "Not Where You Think It Is"
21st March 2014

Many of the largest enterprises face an information crisis in the next few years because they're still focusing on tools rather than capabilities and working with content that is siloed in business units, two recent sets of findings suggest. But, as Tim Buckley Owen discovers, the answer may not be to hire overtrained and overpaid data scientists but to focus on the talent you already have in-house and on how to expand data literacy across the workforce.

Read

Article

Yulia Aspinall Product Review of PharmaCircle: Introduction & Contact Details
21st March 2014

PharmaCircle, an online resource for professionals in the biopharmaceutical industry is reviewed by Yulia Aspinall. The first part of her review introduces the company and product which provides not just information but also analysis on all aspects of the research-based and generic biopharmaceutical business with global coverage of research, development, regulatory, clinical, and business activities.

Read